Mirati Therapeutics, Inc.

Candriam S.C.A.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

893,763

Value ($000)

38,932

Weight

0.3%

2019 Q3 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	38,932	0.3%	893,763	9/30/2023
2023 Q2	8/8/2023	31,569	0.2%	873,763	6/30/2023
2023 Q1	5/12/2023	26,154	0.2%	764,265	3/31/2023
2022 Q4	2/13/2023	34,778	0.2%	767,596	12/31/2022
2022 Q3	11/10/2022	46,271	0.3%	662,501	9/30/2022
2022 Q2	8/3/2022	39,893	0.3%	594,284	6/30/2022
2022 Q1	5/13/2022	41,665	0.3%	506,773	3/31/2022
2021 Q4	2/10/2022	72,242	0.5%	492,483	12/31/2021
2021 Q3	11/9/2021	67,793	0.5%	383,219	9/30/2021
2021 Q2	7/20/2021	55,824	0.4%	345,596	6/30/2021
2021 Q1	4/29/2021	39,896	0.3%	189,100	3/31/2021
2020 Q4	1/22/2021	41,536	0.3%	189,098	12/31/2020
2020 Q3	10/19/2020	22,107	0.2%	133,137	9/30/2020
2020 Q2	7/23/2020	12,566	0.1%	110,061	6/30/2020
2020 Q1	5/26/2020	12,511	0.1%	99,328	3/31/2020
2019 Q4	2/5/2020	12,799	0.1%	99,323	12/31/2019
2019 Q3	2/5/2020	9,528	0.1%	122,300	9/30/2019